Ptc Therapeutics (PTCT) FCF Margin (QoQ) (2012 - 2026)

Ptc Therapeutics (PTCT) FCF Margin (QoQ) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Ptc Therapeutics 5.97 Bn 3.75 Bn 340.60 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 5,731.00
Mar 31, 2026 -515.00
Dec 31, 2025 1,610.00
Sep 30, 2025 29.00
Jun 30, 2025 -10,718.00
Mar 31, 2025 8,666.00
Dec 31, 2024 2,657.00
Mar 31, 2024 6,359.00
Dec 31, 2023 -2,385.00
Sep 30, 2023 370.00
Jun 30, 2023 -92.00
Mar 31, 2023 7,195.00
Dec 31, 2022 -6,534.00
Sep 30, 2022 1,863.00
Jun 30, 2022 3,312.00
Mar 31, 2022 -2,480.00
Dec 31, 2021 -584.00
Sep 30, 2021 -758.00
Jun 30, 2021 5,620.00
Mar 31, 2021 -3,944.00